spacer
home > pmps > winter 2018 > schott’s iqtm platform
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

SCHOTT’S iQTM Platform

More than 600 production lines in 13 countries worldwide produce more than 10 billion syringes, vials, ampoules, cartridges, and special articles of tubing glass or polymer. SCHOTT has more than 130 years of outstanding materials and technology expertise.

iQ™: The Global RTU Standard

Ready-to-use (RTU) filling concepts enable pharma manufacturers to fill syringes, vials, or cartridges in a flexible manner. However, currently available solutions from packaging suppliers require drug manufacturers to fit the filling machines to the specific tub format. This means that the machine needs to be optimised each time to fit the individual products. It also means doing the same work multiple times. With its new iQ platform, SCHOTT addresses this particular issue by standardising ready-to-use syringes, vials, and cartridges within a single tub format to run on the same filling line. By standardising this part of the process, less changing of machine parts is necessary when switching from one container to another as vials, syringes, and cartridges all come in the same tub. Consequently, pharma manufacturers can fill various drug/container configurations on the same filling line with only very short changeover times in between. The development of iQ is based on the proven nest-and-tub format of RTU syringes, which has been used by the pharma industry to fill syringes for decades. Thus, the concept boosts the advantages of RTU filling concepts.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
SCHOTT Pharmaceutical Systems is one of the world’s leading suppliers of parenteral packaging for the pharmaceutical industry
spacer
SCHOTT Pharmaceutical Systems
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Webinar Will Discuss How to Optimize Microbiome Research

BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

10th Annual NGS & Clinical Diagnostics Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 10thAnnual NGS & Clinical Diagnostics Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement